Paul Matteis

Stock Analyst at Stifel

(0)
# 3838
Out of 5,298 analysts
138
Total ratings
29.82%
Success rate
-6.05%
Average return
41 Stocks
Name Action Price Target Current % Upside Ratings Updated
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
300 345
249.66 38.19% 13 Mar 31, 2025
NMRA Neumora Therapeutics
Downgrades: Hold
6 2
0.77 159.74% 2 Mar 7, 2025
RYTM Rhythm Pharmaceutica...
Reinstates: Buy
78
48.14 62.03% 1 Mar 5, 2025
SION Sionna Therapeutics
Initiates Coverage On: Buy
32
11.32 182.69% 1 Mar 4, 2025
CMPS Compass Pathways
Initiates Coverage On: Buy
11
2.69 308.92% 1 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
18 32
9.62 232.64% 2 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
490 494
490.43 0.73% 18 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 32
9.17 248.96% 1 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
10 6
7.24 -17.13% 5 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4
1.06 277.36% 4 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
1.74 474.71% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
44 60
8.96 569.64% 2 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
25 36
30.62 17.57% 7 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
115 87
63.99 35.96% 8 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
41 66
8.63 664.77% 3 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
8.32 320.67% 1 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 53
28.01 89.22% 5 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 21
15.72 33.59% 5 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
29
5.98 384.95% 1 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
141 144
96.65 48.99% 8 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
315 287
127.09 125.82% 6 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
2.46 713.01% 1 Nov 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
2.21 442.99% 1 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
24
1.1 2081.82% 2 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
260 295
n/a n/a 4 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
50 54
n/a n/a 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
36 5
0.27 1751.85% 2 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
54 32
10.51 204.47% 1 Jun 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
1.62 1381.48% 1 Feb 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
n/a n/a 1 Sep 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
0.96 2712.5% 1 Jul 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 23
n/a n/a 2 Dec 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
150 140
n/a n/a 7 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
6.8 105.88% 1 Mar 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
60
n/a n/a 6 Nov 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3000 2280
n/a n/a 1 Oct 5, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
25 31
n/a n/a 2 Sep 25, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 18
n/a n/a 2 Feb 27, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
53 64
6.32 912.66% 1 Feb 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28 22
n/a n/a 2 Oct 9, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
340
16.84 1919% 1 Dec 21, 2016